Bakuchiol vs Retinol: The "Plant-Based Retinol" Story Rests on One Small Trial. Here's What It Actually Found.

Bakuchiol is sold as the sensible person's retinol. "Plant-based, pregnancy-friendly, works as well as retinol without the irritation" — some version of that line is printed on almost every serum that contains it. It sounds like an unusually clean win: a natural ingredient that finally beats the harsh synthetic at its own job.

The strange thing is how much of that pitch traces back to a single 44-person trial from 2018. The trial is real. It's also small, short, and one of only a handful of head-to-head comparisons that exist. That gap between "one promising study" and "as effective as retinol" is where most of the marketing lives.

Here's what the research actually shows, and where the honest limits are.

What Bakuchiol Is (and Isn't)

Bakuchiol is a meroterpene phenol extracted from the seeds of Psoralea corylifolia, a plant used in traditional Indian and Chinese medicine long before anyone was writing serum labels. Chemically, it has no structural resemblance to retinol. The reason it gets marketed as a "retinol alternative" comes from lab work — most famously a 2014 gene-expression study — showing that bakuchiol switches on many of the same skin genes that retinol does, even though the two molecules look nothing alike. That's the functional-analog claim: same downstream effect, different key in the lock.

That mechanism story is genuinely interesting. It is not, on its own, proof that bakuchiol matches retinol on skin.

The One Real Head-to-Head Trial

There is really only one clinical trial that put bakuchiol and retinol on the same face at the same time under blinded conditions. Dhaliwal et al., published in the British Journal of Dermatology in 2019, ran a 12-week randomised, double-blind study of 44 people. One side of each face got 0.5% bakuchiol cream twice daily; the other got 0.5% retinol cream once daily. A blinded dermatologist rated pigmentation, redness and wrinkling at weeks 0, 4, 8 and 12.

The findings are worth stating carefully:

That last row matters more than the headlines suggest. Prescription retinoid use is often a multi-year story: the benefits on fine lines and pigmentation compound past the first three months, and so does tolerance. A 12-week snapshot can't tell you whether bakuchiol keeps pace at month 9. It also can't tell you how it compares to 0.1% adapalene or tretinoin — the actually strong retinoids most dermatologists reach for — because the trial used cosmetic-grade 0.5% retinol.

What the Broader Review Evidence Says

Beyond that one trial, most of the bakuchiol literature is either in-vitro (cells in a dish), on animals, or on bakuchiol formulations tested against placebo rather than against retinol. A 2022 systematic review in the Journal of Cosmetic Dermatology found roughly seven clinical studies in humans across all indications combined — a small stack compared to the thousands of published papers on topical retinoids. A more recent narrative review in the Journal of Integrative Dermatology reaches a careful conclusion: bakuchiol shows "comparable efficacy and better tolerability" to retinol in the studies that exist, but the clinical evidence base is "still in its infancy."

That's the honest read. Bakuchiol is a promising ingredient with a real signal in a small evidence base. Retinoids are an established ingredient with a large evidence base. Both things are true.

Is Bakuchiol Actually Safer in Pregnancy?

This is the claim that gets the ingredient into a lot of shopping baskets, and it deserves an unusually careful answer.

Oral high-dose vitamin A is definitively teratogenic — that's not controversial. Topical retinoids are classified by the US FDA as Pregnancy Category C: risk to a fetus can't be ruled out from animal data, but human evidence of harm from topical use is thin. Most obstetricians tell patients to stop topical retinoids in pregnancy anyway, on the grounds that the theoretical risk isn't worth it when the reason for using retinol is cosmetic.

Bakuchiol is chemically unrelated to vitamin A and doesn't act on retinoid receptors, so the mechanism that makes retinoids a pregnancy concern isn't there. But — and this is the part rarely printed on the box — there is no clinical safety data on bakuchiol in pregnancy either. "Different mechanism, so probably fine" is the honest position, not "proven safe." Anyone actually pregnant should still check with their obstetrician before adding it in.

How Long Does Bakuchiol Take to Work?

If you're going to try it, expect the same timeline any serious skincare ingredient asks for: 8 to 12 weeks of consistent use before judging it, minimum. That's what the trials measured, and it lines up with how skin turnover actually works. A two-week "I don't see anything" verdict isn't a fair test.

A few practical notes from the trial data and formulation literature:

• Concentrations in the studies with the strongest data cluster around 0.5% to 1%. Serums that only list bakuchiol far down the ingredient list, without disclosing the percentage, may be trading on the name without the dose.
• Bakuchiol pairs cleanly with vitamin C, niacinamide and peptides — there's no known interaction problem. This is different from retinol, which some people find they can't layer with acids without irritation.
• It does not replace sunscreen. Nothing does. If you're using bakuchiol for pigmentation, daily SPF is doing more of the work than the serum.

So Should You Switch From Retinol to Bakuchiol?

The reasonable framing isn't "which is better" — it's "which is right for you, right now."

Bakuchiol is worth considering if you can't tolerate retinoids (real sensitivity, not just a rough first week), you're pregnant or nursing and want something addressing texture and tone with a lower theoretical risk, or you've bounced off retinol repeatedly and need a gentler entry point.

Stay with a retinoid if you're using a prescription-strength one that's working, you're targeting deeper wrinkles or stubborn hyperpigmentation where the evidence base is genuinely stronger, or your skin already tolerates it. "Bakuchiol matched retinol in one 12-week trial at 0.5%" is not a reason to abandon a routine that's giving you results.

The most useful thing to take from the research isn't that bakuchiol wins or loses. It's that a lot of skincare marketing has learned to launder "one small study" into "clinically proven equivalent" — and knowing the difference is how you stop being sold to.